|
patient
|
2-S16 |
|
Age
|
35 |
|
Dose(mg)
|
1 |
|
Cervical lesion size
|
>50% |
|
V1(Histology)
|
CIN3 |
|
V1 (HPV)
|
16 |
|
V7(Histology)
|
NIL |
|
V7 (HPV)
|
Neg |
|
V7 histopatholgic regression
|
Yes |
|
V7 HPV clearance
|
Yes |
|
V8(Histology)
|
NIL |
|
V8 (HPV)
|
Neg |
|
V8 histopatholgic regression
|
Yes |
|
V8 HPV Clearance
|
Yes |
|
Included in V7 (20weeks after 1st injection)analysis
|
Yes |
|
Included in V8 (36weeks after 1st injection) analysis
|
Yes |
|
HPV nucleotide sequencing
|
Yes |
Virus Dataset Sample Detail